BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Zongtai Li, Xiaofang Zou, Liangxi Xie, Hongmei Dong, Yuping Chen, Qing Liu, Xiao Wu, David Zhou, Dongfeng Tan, Hao Zhang, Nikki Pui-yue Lee. Prognostic Importance and Therapeutic Implications of PAK1, a Drugable Protein Kinase, in Gastroesophageal Junction AdenocarcinomaPLoS ONE 2013; 8(11): e80665 doi: 10.1371/journal.pone.0080665
2
Christoph Schulz, Frank Kullmann, Volker Kunzmann, Martin Fuchs, Michael Geissler, Ursula Vehling-Kaiser, Heribert Stauder, Axel Wein, Salah-Eddin Al-Batran, Thomas Kubin, Claus Schäfer, Sebastian Stintzing, Clemens Giessen, Dominik Paul Modest, Karsten Ridwelski, Volker Heinemann. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumorsInternational Journal of Cancer 2015; 137(3): 678 doi: 10.1002/ijc.29403
3
Amy T. Y. Chang, Wai Tong Ng, Ada L. Y. Law, Ki Man Ku, Michael C. H. Lee, Anne W. M. Lee. Adjuvant chemoradiation for resected gastric cancer: a 10-year experienceGastric Cancer 2011; 14(1): 63 doi: 10.1007/s10120-011-0011-y
4
Yan Yi, Jinming Yu, Baosheng Li, Fujun Yang, Wei Huang, Hongfu Sun, Heyi Gong, Tao Zhou, Haiqun Lin. Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume delineation of regional lymph node in patients with gastric carcinomaRadiotherapy and Oncology 2010; 96(2): 223 doi: 10.1016/j.radonc.2010.04.031
5
Hong Ma, Jun Han, Tao Zhang, Yang Ke. Comparison of dosiology between three dimensional conformal and intensity-modulated radiotherapies (5 and 7 fields) in gastric cancer post-surgeryJournal of Huazhong University of Science and Technology [Medical Sciences] 2013; 33(5): 759 doi: 10.1007/s11596-013-1193-9
6
J. Arredondo, C. Pastor, J. Baixauli, J. Rodríguez, I. González, C. Vigil, A. Chopitea, J. L. Hernández-Lizoáin. Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancerColorectal Disease 2013; 15(5): 552 doi: 10.1111/codi.12119
7
Zongtai Li, Xiaofang Zou, Liangxi Xie, Hongcai Chen, Yuping Chen, Sai-Ching Jim Yeung, Hao Zhang. Personalizing risk stratification by addition of PAK1 expression to TNM staging: Improving the accuracy of clinical decision for gastroesophageal junction adenocarcinomaInternational Journal of Cancer 2015; 136(7): 1636 doi: 10.1002/ijc.29167
8
Jean M. Butte, Enrique Waugh, Hugo Parada, Hernán De La Fuente. Combined total gastrectomy, total esophagectomy, and D2 lymph node dissection with transverse colonic interposition for adenocarcinoma of the gastroesophageal junctionSurgery Today 2011; 41(9): 1319 doi: 10.1007/s00595-010-4412-z
9
Jamie D. Croxtall, Kate McKeage. Trastuzumab in HER2-Positive Metastatic Gastric Cancer†BioDrugs 2011; 25(4): 257 doi: 10.2165/11207110-000000000-00000
10
Hongmei Dong, Hong Guo, Liangxi Xie, Geng Wang, Xueyun Zhong, Thaer Khoury, Dongfeng Tan, Hao Zhang, Anthony WI. Lo. The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction AdenocarcinomaPLoS ONE 2013; 8(5): e62986 doi: 10.1371/journal.pone.0062986
11
Hua Zhao, Yongli Fan, Hui Li, Jinpu Yu, Liang Liu, Shui Cao, Baozhu Ren, Fang Yan, Xiubao Ren. Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 PatientsCancer Biotherapy and Radiopharmaceuticals 2013; 28(4): 303 doi: 10.1089/cbr.2012.1306
12
Armin Wiegering, Meik Kunz, Mohamed Hussein, Ingo Klein, Verena Wiegering, Friedrich Wilhelm Uthe, Ulrich A. Dietz, Christian Jurowich, Thorsten Bley, Thomas Dandekar, Christoph-Thomas Germer, Christian Ritter. Diagnostic value of preoperative CT scan to stratify colon cancer for neoadjuvant therapyInternational Journal of Colorectal Disease 2015; 30(8): 1067 doi: 10.1007/s00384-015-2265-z
13
Mario Scartozzi, Walter Siquini, Elena Maccaroni, Maristella Bianconi, Riccardo Giampieri, Rossana Berardi, Stefano Cascinu. Surgery in the Multimodal Management of Gastric Cancer2012; : 187 doi: 10.1007/978-88-470-2318-5_24
14
Massimo Bellini, Dario Gambaccini, Gabrio Bassotti. Comorbidities in functional gastrointestinal diseases: Do we need a lone ranger or a dream team?Digestive and Liver Disease 2016; 48(5): 562 doi: 10.1016/j.dld.2016.02.011
15
Oscar Matzinger, Erich Gerber, Zvi Bernstein, Philippe Maingon, Karin Haustermans, Jean François Bosset, Akos Gulyban, Philip Poortmans, Laurence Collette, Abraham Kuten. EORTC-ROG expert opinion: Radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomachRadiotherapy and Oncology 2009; 92(2): 164 doi: 10.1016/j.radonc.2009.03.018
16
Gianluca Tomasello, Matteo Dalla Chiesa, Sebastiano Buti, Matteo Brighenti, Federica Negri, Rodrigo Kraft Rovere, Mario Martinotti, Massimo Buononato, Antonio Brunelli, Silvia Lazzarelli, Gianvito Donati, Rodolfo Passalacqua. Dose-dense Chemotherapy in Metastatic Gastric Cancer with a Modified Docetaxel-Cisplatin-5-Fluorouracil RegimenTumori Journal 2010; 96(1): 48 doi: 10.1177/030089161009600108
17
Linda Agolli, Luca Nicosia. Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?World Journal of Gastrointestinal Oncology 2018; 10(9): 271-281 doi: 10.4251/wjgo.v10.i9.271
18
Yeon Jin Kim, Jaeseung Lim, Jong Soon Kang, Hwan Mook Kim, Hong Kyung Lee, Hwa Sun Ryu, Jee Youn Kim, Jin Tae Hong, Youngsoo Kim, Sang-Bae Han. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cellsArchives of Pharmacal Research 2010; 33(11): 1789 doi: 10.1007/s12272-010-1111-7
19
H. Dong, L. Xie, C. Tang, S. Chen, Q. Liu, Q. Zhang, W. Zheng, Z. Zheng, H. Zhang. Snail1 correlates with patient outcomes in E-cadherin-preserved gastroesophageal junction adenocarcinomaClinical and Translational Oncology 2014; 16(9): 783 doi: 10.1007/s12094-013-1149-3
20
B. Xiong, L. Ma, Y. Cheng, C. Zhang. RETRACTED: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of randomized controlled trialsEuropean Journal of Surgical Oncology (EJSO) 2014; 40(10): 1321 doi: 10.1016/j.ejso.2014.01.006
21
Dong Shen, Zhi-Hao Liu, Jia-Ning Xu, Fang Xu, Qin-Feng Lin, Feng Lin, Wei-Dong Mao. Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysisImmunotherapy 2016; 8(8): 971 doi: 10.2217/imt.16.10
22
Binghong Xiong, Li Ma, Wei Huang, Yong Cheng, Qikang Zhao, Jingshan Liu. WITHDRAWN: Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: An updated meta-analysis of 12 randomized controlled trialsSurgical Oncology 2014;  doi: 10.1016/j.suronc.2014.11.005
23
Jeremy J. Erasmus, Eric M. Rohren, Roland Hustinx. PET and PET/CT in the Diagnosis and Staging of Esophageal and Gastric CancersPET Clinics 2008; 3(2): 135 doi: 10.1016/j.cpet.2008.09.002
24
Jamie D. Croxtall, Kate McKeage. TrastuzumabDrugs 2010; 70(17): 2259 doi: 10.2165/11205900-000000000-00000
25
Christopher Ganser, Eva Lauermann, Annett Maderer, Torsten Stauder, Jan-Peter Kramb, Stanislav Plutizki, Thomas Kindler, Markus Moehler, Gerd Dannhardt. Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative ActivityJournal of Medicinal Chemistry 2012; 55(22): 9531 doi: 10.1021/jm301217c
26
Linda Agolli, Riccardo Maurizi Enrici, Mattia Falchetto Osti. Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?World Journal of Gastroenterology 2016; 22(3): 1131-1138 doi: 10.3748/wjg.v22.i3.1131